SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,240.00    30.00 (2.46%)
Bid:
1,230.00
Ask:
1,250.00
Spread: 20.00 (1.626%)
Market Cap: £369.26m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Offer for Celtic Resources

9 Nov 2007 18:34

OAO Severstal09 November 2007 Severstal Resurs and Celtic Agree Basis for Recommended Offer Moscow 9 November 2007 Severstal Resurs is pleased to announce that it has reached agreement on theterms of a recommended acquisition by Severstal Resurs, through its affiliateCentroferve Limited, of the entire issued and to be issued share capital ofCeltic Resources Holdings plc ("Celtic"). Severstal, through Centroferve, has agreed to increase its offer to 280 penceper share in cash, effective immediately, and to 290 pence per share in cash, inthe event that Centroferve receives acceptances to its offer equivalent to 80%of Celtic's issued share capital. This would entitle Severstal Resurs toproceed with a compulsory acquisition of any remaining shares outstanding inaccordance with the Irish Takeover Rules. At a price of 290 pence per share, the terms of the transaction represent: • a premium of approximately 43% to the closing price of Celtic shareson 17 September 2007, the day prior to an announcement by Celtic that it hadreceived an approach from Severstal Resurs • a premium of approximately 52% to the one month volume weightedaverage share price for the period to 17 September 2007 • a premium of approximately 54% to the three month volume weightedaverage share price for the period to 17 September 2007 The board of Celtic unanimously recommends this offer to its shareholders.Celtic's directors have indicated that they intend to accept the Offer withrespect to their own 9.0% stake in Celtic. Severstal has already received anirrevocable undertaking from Bluecone Limited to accept its offer with respectto its 29.7% stake in Celtic, as well as a letter of intent from Barrick GoldCorporation to accept the offer with respect to its 6.6% stake in Celtic. As aresult, Centroferve has received support from shareholders representing 45.3% ofCeltic's shares to accept its offer. Commenting on the Offer on behalf of the Centroferve Board, Roman Deniskin, CEOof Severstal Resurs, said: "Severstal is delighted to have reached agreement with the Board of Celtic. Wewelcome Celtic's recommendation that shareholders should now accept our generouscash offer." Enquiries: Centroferve Tel: +7 495 9810910 ext.6633Roman DeniskinNikolai Zelenski Morgan Stanley & Co. Limited Tel: +44 20 7425 8000Peter BacchusArash Mahdaviani FD London Tel: +44 207 831 3113Jon SimmonsBen Brewerton This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Nov 20226:29 pmRNSPDMR and PCA shareholding
30th Nov 202211:18 amRNSHolding(s) in Company
28th Nov 20227:00 amRNSFinal Results
23rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
2nd Nov 20225:49 pmRNSHolding(s) in Company
2nd Nov 202212:40 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSRelease of latest version of flagship product set
24th Oct 20227:00 amRNSTrading Update
6th Oct 20227:00 amRNSAppointment of Joint Broker
25th Aug 20223:48 pmRNSGrant of Options
8th Aug 20223:08 pmRNSHolding(s) in Company
28th Jul 20224:35 pmRNSPrice Monitoring Extension
19th Jul 20227:00 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSMajor Contract Win
13th May 20227:33 amRNSDirector Share Purchase
9th May 20227:00 amRNSInterim Results Presentation
9th May 20227:00 amRNSInterim Results
25th Apr 202210:13 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSH1 2022 Trading Update
6th Apr 20227:00 amRNSCerillion Client MVN-X Reaches Million Subscribers
7th Mar 20227:00 amRNSWins Prestigious Megabuyte Performance Award
2nd Mar 20227:00 amRNSExercise of Options, PDMR Shareholding & TVR
21st Feb 20223:08 pmRNSHolding(s) in Company
21st Feb 20227:00 amRNSShare purchase for Employee Share Option Scheme
15th Feb 20227:00 amRNSRecognised in Two Gartner Market Guide Reports
4th Feb 202211:37 amRNSResult of AGM
31st Jan 20227:00 amRNSConfirmation of Board Appointment
27th Jan 20222:25 pmRNSHolding(s) in Company
24th Jan 20222:05 pmRNSSecond Price Monitoring Extn
24th Jan 20222:00 pmRNSPrice Monitoring Extension
10th Jan 20227:00 amRNSCompletion of Implementation for Norlys
14th Dec 20217:00 amRNSBoard Retirement and Proposed Appointment
26th Nov 20218:37 amRNSPDMR and PCA Shareholding
22nd Nov 20217:00 amRNSFinal Results
16th Nov 20212:42 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSRelease of Cerillion 21.2
4th Oct 20217:02 amRNSTrading Update
28th Sep 20217:00 amRNSContracts worth £4.2m with OpenNet
23rd Sep 20216:15 pmRNSHolding(s) in Company
9th Sep 20217:00 amRNSOpening of Bulgaria office
8th Sep 20217:00 amRNSInvestor Presentation
22nd Jul 20214:24 pmRNSHolding(s) in Company
13th Jul 202111:03 amRNSHolding(s) in Company
6th Jul 202111:30 amRNSDirector/PDMR Shareholding
22nd Jun 20217:00 amRNSGrant of Options
18th Jun 20217:00 amRNSEmployee Share Option Scheme
10th Jun 202111:35 amRNSDirector/PDMR shareholding
27th May 20216:03 pmRNSReplacement: Director/PDMR Shareholding
27th May 20213:50 pmRNSDirector/PDMR Shareholding
24th May 20214:59 pmRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.